Purchase Order 36C25626P0449
- Not listed
- The U.S. Department of Veterans Affairs (VA) awarded a $45,640.00 firm-fixed-price purchase order to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems. The contract is for the delivery of surgical implants, specifically neurostimulators and related devices, to be used in the treatment of neurological disorders, particularly epilepsy, for veterans. The contract has an ultimate completion date of December 6, 2024. Neuropace Inc. has a history of...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a firm fixed-price purchase order to Neuropace Inc. on November 21, 2025, for the procurement of surgical implants with a ceiling value of $47,020. The contract, which will be performed in Mountain View, California, represents a full and open competition award with no set-aside designation. The ultimate completion date is February 20, 2026. Neuropace Inc., a medical device manufacturer specializing in...
- Neuropace Inc., a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems, was awarded a firm fixed-price purchase order on December 17, 2025, by Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs. The contract, valued at $37,600, calls for the delivery of a prosthetics neurostimulator implant and is scheduled for completion by January 31, 2026. No set-aside designation was used in this full and open...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a $36.3K firm fixed-price purchase order to Neuropace Inc. on March 11, 2026, for neurostimulator devices with an ultimate completion date of April 13, 2026. This contract was awarded without set-aside designation through full and open competition. Neuropace Inc., a Mountain View, California-based medical device manufacturer, specializes in implantable neurostimulation systems designed to treat...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Neuropace Inc., a medical device manufacturer based in Mountain View, California. The contract is for a surgical implant, with a ceiling value of $47,020.00 and a performance period ending on December 19, 2025. The contract was awarded on a full and open competition basis, with no set-aside designations. Neuropace specializes in implantable neurostimulation systems, particularly the RNS System,...
- The federal contract award, valued at $56,300.00, was issued by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs (VA), to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems. The contract is for the provision of surgical implants, which are primarily focused on supporting veterans with neurological disorders, particularly epilepsy. The contract is a firm fixed-price purchase order and was...
- This $43,900 firm-fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems. The contract is for the delivery of surgical implants, specifically Neuropace's RNS System, a responsive neurostimulation device for treating focal onset seizures in individuals with epilepsy. The contract has an ultimate completion date of November 27, 2023, and is part of the VA's...
- This is a federal contract award to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems for treating neurological disorders, particularly epilepsy. The contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12), is for the purchase of DEVICE - 607, a type of surgical implant or prosthetic device for veterans. The $36,300.00 firm fixed price contract has a period of performance ending on July 10, 2024....
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Neuropace Inc., a medical device manufacturer based in Mountain View, California. The contract, valued at $47,020.00, is for the procurement of prosthetic implants. The contract is a firm fixed-price purchase order with an ultimate completion date of August 29, 2025. This award was made on a full and open competition basis without any small business set-aside designation. Neuropace is a for-profit...
- This is a $47,020.00 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems. The contract is for the provision of surgical implants, specifically neurostimulators and related medical devices, to support the VA's healthcare services. This award falls under the VA's Veterans Integrated Service Network (VISN) 17, which covers parts of Texas and Oklahoma. The...
The Department of Veterans Affairs' Veterans Integrated Service Network 17 awarded a $47,970 firm fixed-price purchase order to Neuropace Inc. on March 5, 2026, for the provision of surgical implants with an ultimate completion date of June 5, 2026. This contract was awarded through full and open competition with no set-aside designation. Neuropace, a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems for treating neurological disorders such as epilepsy, has established itself as a primary supplier to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks, consistently delivering neurostimulator devices, electrodes, and associated surgical supplies. This award aligns with the VA's broader mission to provide specialized medical devices and innovative treatment options to veteran populations. Neuropace's federal procurement history demonstrates consistent performance in delivering high-quality implantable devices through competitive acquisition processes, with recent contract activity across multiple VA networks and the National Institutes of Health. Beyond procurement contracts, the company maintains an active cooperative agreement with the National Institutes of Health focused on advancing responsive neurostimulation therapies for treatment-resistant epilepsy, underscoring its role in both clinical operations and cutting-edge neurostimulation research within the federal healthcare ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.0k | 3/4/26 |